Stock Scorecard



Stock Summary for Veeva Systems Inc - Class A (VEEV) - $273.00 as of 11/19/2025 9:33:53 PM EST

Total Score

14 out of 30

Safety Score

61 out of 100

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for VEEV

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for VEEV

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for VEEV

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for VEEV

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for VEEV (61 out of 100)

Stock Price Rating (Max of 10) 10
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 7
Book Value (Max of 10) 8
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 5
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 5
Trading Volume (Max of 10) 9
Price to Earnings (Max of 10) 2
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for VEEV

Veeva ( VEEV ) Is Considered a Good Investment by Brokers: Is That True? 11/18/2025 2:30:00 PM
Here's How Much $100 Invested In Veeva Systems 10 Years Ago Would Be Worth Today - Veeva Systems ( NYSE:VEEV ) 11/17/2025 4:30:00 PM
Unveiling Veeva ( VEEV ) Q3 Outlook: Wall Street Estimates for Key Metrics 11/17/2025 2:15:00 PM
Biotricity Inc. ( BTCY ) Reports Q2 Loss, Lags Revenue Estimates 11/14/2025 10:00:00 PM
Why Veeva Systems ( VEEV ) Dipped More Than Broader Market Today 11/13/2025 10:45:00 PM
Veeva Systems ( VEEV ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release 11/13/2025 3:00:00 PM
Veeva Systems Inc. ( VEEV ) Is a Trending Stock: Facts to Know Before Betting on It 11/13/2025 2:00:00 PM
This Gilead Sciences Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - CoreWeave ( NASDAQ:CRWV ) , CPS Technologies ( NASDAQ:CPSH ) 11/13/2025 1:45:00 PM
DarioHealth Corp. ( DRIO ) Reports Q3 Loss, Lags Revenue Estimates 11/13/2025 12:45:00 PM
2 Top Stocks That Can Supercharge Your Portfolio in 2026 and Beyond 11/13/2025 11:30:00 AM

Financial Details for VEEV

Company Overview

Ticker VEEV
Company Name Veeva Systems Inc - Class A
Country USA
Description Veeva Systems Inc. Class A is a leading provider of cloud-based software solutions tailored for the life sciences sector, empowering organizations to enhance their operational efficiency and regulatory compliance. Headquartered in Pleasanton, California, Veeva offers a comprehensive suite of applications that span clinical trials, quality management, and commercial operations, servicing clients globally across North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America. With its innovative technology and deep industry expertise, Veeva is well-positioned to capitalize on the growing demand for digital transformation within the life sciences industry.
Sector Name HEALTHCARE
Industry Name HEALTH INFORMATION SERVICES
Most Recent Quarter 7/31/2025
Next Earnings Date 11/20/2025

Stock Price History

Last Day Price 273.00
Price 4 Years Ago 255.48
Last Day Price Updated 11/19/2025 9:33:53 PM EST
Last Day Volume 1,232,655
Average Daily Volume 1,011,526
52-Week High 310.50
52-Week Low 201.54
Last Price to 52 Week Low 35.46%

Valuation Measures

Trailing PE 57.12
Industry PE 173.55
Sector PE 115.35
5-Year Average PE 51.72
Free Cash Flow Ratio 23.17
Industry Free Cash Flow Ratio 29.21
Sector Free Cash Flow Ratio 27.55
Current Ratio Most Recent Quarter 5.57
Total Cash Per Share 11.78
Book Value Per Share Most Recent Quarter 40.51
Price to Book Ratio 7.24
Industry Price to Book Ratio 4.81
Sector Price to Book Ratio 33.20
Price to Sales Ratio Twelve Trailing Months 15.30
Industry Price to Sales Ratio Twelve Trailing Months 4.28
Sector Price to Sales Ratio Twelve Trailing Months 16.69
Analyst Buy Ratings 14
Analyst Strong Buy Ratings 8

Share Statistics

Total Shares Outstanding 163,908,000
Market Capitalization 44,746,884,000
Institutional Ownership 90.04%

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 14.40%
Annual Earnings Growth 35.84%
Reported EPS 12 Trailing Months 4.85
Reported EPS Past Year 3.96
Reported EPS Prior Year 5.99
Net Income Twelve Trailing Months 809,932,000
Net Income Past Year 714,138,000
Net Income Prior Year 525,705,000
Quarterly Revenue Growth YOY 16.70%
5-Year Revenue Growth 19.99%
Operating Margin Twelve Trailing Months 28.70%

Balance Sheet

Total Cash Most Recent Quarter 1,930,431,000
Total Cash Past Year 1,118,785,000
Total Cash Prior Year 703,487,000
Net Cash Position Most Recent Quarter 1,930,431,000
Net Cash Position Past Year 1,118,785,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 5,832,373,000
Total Stockholder Equity Prior Year 4,644,824,000
Total Stockholder Equity Most Recent Quarter 6,638,539,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 1,328,048,000
Free Cash Flow Per Share Twelve Trailing Months 8.10
Free Cash Flow Past Year 1,069,532,000
Free Cash Flow Prior Year 885,143,000

Options

Put/Call Ratio 0.27
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.79
MACD Signal 0.60
20-Day Bollinger Lower Band 268.29
20-Day Bollinger Middle Band 284.15
20-Day Bollinger Upper Band 300.00
Beta 1.04
RSI 37.75
50-Day SMA 256.14
150-Day SMA 215.84
200-Day SMA 209.35

System

Modified 11/18/2025 11:44:38 PM EST